Daniel J. Estes
Direttore/Membro del Consiglio presso Semnur Pharmaceuticals, Inc.
Provenienza dei contatti di primo grado di Daniel J. Estes
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Michigan
428
| College/University | Other Consumer Services | 428 |
Stanford University
263
| College/University | Other Consumer Services | 263 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.
126
| Subsidiary | Investment Managers | 126 |
| Public Company | Pharmaceuticals: Major | 23 | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.
15
| Private Company | Miscellaneous Commercial Services | 15 |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.
15
| Holding Company | Biotechnology | 15 |
| Extinct | Biotechnology | 9 | |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Inipharm, Inc.
 Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Inipharm, Inc. provides health care services. The company was founded by Brian Farmer and Mike Gallatin in 2018 and is headquartered in Bellevue, WA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd.
3
| Holding Company | Information Technology Services | 3 |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Daniel J. Estes tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Comptroller/Controller/Auditor | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Private Equity Investor | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Administrative Officer | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Corporate Officer/Principal | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Investor Relations Contact General Counsel Corporate Officer/Principal Human Resources Officer | |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Founder Founder Founder | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member Founder | |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Pharmaceuticals: Major | Founder Founder | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| XENOPORT, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Indiana University | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University | College/University | Masters Business Admin Graduate Degree | |
| Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Iowa | College/University | Undergraduate Degree Undergraduate Degree | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Research - Equity Founder Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman | |
Hawkeye Therapeutics, Inc.
 Hawkeye Therapeutics, Inc. BiotechnologyHealth Technology Hawkeye Therapeutics, Inc. licenses and develops assets from pharmaceutical companies. The company is headquartered in San Diego, CA. | Biotechnology | Founder Chief Executive Officer Founder | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Founder Director/Board Member Founder Founder | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Founder | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Paesi Bassi | 3 |
Settori
| Health Technology | 31 |
| Consumer Services | 18 |
| Finance | 3 |
| Retail Trade | 2 |
Posizioni
| Director/Board Member | 444 |
| Corporate Officer/Principal | 202 |
| Independent Dir/Board Member | 112 |
| Undergraduate Degree | 86 |
| Founder | 82 |
Contatti più connessi
| Insiders | |
|---|---|
| James Topper | 49 |
| Jonathan Silverstein | 42 |
| Mahendra Shah | 34 |
| Alan Frazier | 31 |
| Edgar Engleman | 29 |
| Dennis Fenton | 28 |
| Mike J. Jandernoa | 28 |
| Nilesh Kumar | 26 |
| David Topper | 25 |
| Peter Moldt | 25 |
| Ricky Sun | 24 |
| David Socks | 24 |
| Robert F. Baltera | 23 |
| Joseph Turner | 22 |
| Paul Grayson | 21 |
- Borsa valori
- Insiders
- Daniel J. Estes
- Connessioni Società
